 |
|
 |
| Welcome to Pharmacogenomics, the definitive journal for the post-genomic era, bringing you news, views and opinions in personalized medicine and genome research, both in print and on the web
|
Increased frequency: Pharmacogenomics will increase its frequency for 2004 from six to eight issues annually!
Pharmacogenetics and public policy: expert views in Europe and North America.....
The new genetics is stimulating the development of genetic testing of patients to help choose the best drug, adjust doses and avoid side effects. Proponents say that this personalized medicine will revolutionize drug development and healthcare. In a series of group meetings, 48 leading experts from regulatory agencies, industry, academia and consumer interests gave their opinions on the public policy priorities. An Ethical Perspective article by D Melzer, D Detmer and R Zimmern
Also in the November issue of Pharmacogenomics..... exceptional reviews on: Pharmacogenomics of diuretic drugs, Applications of genomics in the inner ear, Pharmacogenomics in the treatment of epilepsy and much more.........
|
|
|
|
|
|
|
|
|
|